HDAC11 and metabolic dysfunction-associated steatotic liver disease: In conclusion, this study provides a critical insight into the development of novel therapeutic approaches for MASLD and elucidate the molecular mechanisms underlying HDAC11‐mediated regulation of energy metabolism.